Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215376120. doi: 10.1073/pnas.2215376120. Epub 2023 Mar 10.
Proc Natl Acad Sci U S A. 2023.
PMID: 36897988
Free PMC article.
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Mabe NW, Huang M, Dalton GN, Alexe G, Schaefer DA, Geraghty AC, Robichaud AL, Conway AS, Khalid D, Mader MM, Belk JA, Ross KN, Sheffer M, Linde MH, Ly N, Yao W, Rotiroti MC, Smith BAH, Wernig M, Bertozzi CR, Monje M, Mitsiades CS, Majeti R, Satpathy AT, Stegmaier K, Majzner RG.
Mabe NW, et al.
Nat Cancer. 2022 Aug;3(8):976-993. doi: 10.1038/s43018-022-00405-x. Epub 2022 Jul 11.
Nat Cancer. 2022.
PMID: 35817829
Free PMC article.
Item in Clipboard
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Theruvath J, Menard M, Smith BAH, Linde MH, Coles GL, Dalton GN, Wu W, Kiru L, Delaidelli A, Sotillo E, Silberstein JL, Geraghty AC, Banuelos A, Radosevich MT, Dhingra S, Heitzeneder S, Tousley A, Lattin J, Xu P, Huang J, Nasholm N, He A, Kuo TC, Sangalang ERB, Pons J, Barkal A, Brewer RE, Marjon KD, Vilches-Moure JG, Marshall PL, Fernandes R, Monje M, Cochran JR, Sorensen PH, Daldrup-Link HE, Weissman IL, Sage J, Majeti R, Bertozzi CR, Weiss WA, Mackall CL, Majzner RG.
Theruvath J, et al.
Nat Med. 2022 Feb;28(2):333-344. doi: 10.1038/s41591-021-01625-x. Epub 2022 Jan 13.
Nat Med. 2022.
PMID: 35027753
Free PMC article.
Item in Clipboard
Small RNAs are modified with N-glycans and displayed on the surface of living cells.
Flynn RA, Pedram K, Malaker SA, Batista PJ, Smith BAH, Johnson AG, George BM, Majzoub K, Villalta PW, Carette JE, Bertozzi CR.
Flynn RA, et al.
Cell. 2021 Jun 10;184(12):3109-3124.e22. doi: 10.1016/j.cell.2021.04.023. Epub 2021 May 17.
Cell. 2021.
PMID: 34004145
Free PMC article.
Item in Clipboard
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.
Wisnovsky S, Möckl L, Malaker SA, Pedram K, Hess GT, Riley NM, Gray MA, Smith BAH, Bassik MC, Moerner WE, Bertozzi CR.
Wisnovsky S, et al.
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2015024118. doi: 10.1073/pnas.2015024118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33495350
Free PMC article.
Item in Clipboard
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.
Smith BAH, Bertozzi CR.
Smith BAH, et al.
Nat Rev Drug Discov. 2021 Mar;20(3):217-243. doi: 10.1038/s41573-020-00093-1. Epub 2021 Jan 18.
Nat Rev Drug Discov. 2021.
PMID: 33462432
Free PMC article.
Review.
Item in Clipboard
Cite
Cite